Charles River Laboratories (CRL) Tops Q3 EPS by 15c
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $286.07 +2.15%
Financial Fact:
Discontinued operations (in dollars per share): 0.01
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Discontinued operations (in dollars per share): 0.01
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q3 EPS of $1.53, $0.15 better than the analyst estimate of $1.38. Revenue for the quarter came in at $585.3 million versus the consensus estimate of $567.79 million.
GUIDANCE:
Charles River Laboratories sees FY2018 EPS of $5.87-$5.97, versus the consensus of $5.92.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
- BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
- Wendy's U.S. president to resign, company to create COO role
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
